how it works

Learn more about the components that make up Dexcom G6 Pro and how to maximize its impact on your practice.

a closer look at Dexcom G6 Pro components

Dexcom G6 Pro single-use applicators, sensors, and transmitters are bundled together in one box, while the Dexcom reader comes in its own box. Take a deeper dive into each of the components and how they work with the Dexcom G6 app and Dexcom Clarity to support your patients.

1. Applicator

The one-touch applicator allows for simple sensor insertion.¹

2. Single-use transmitter + sensor

The disposable transmitter auto-starts for expedited startup time.

3. Reader

The reader verifies session start and is for office use only. It does not display any CGM data. As a compatible data extraction tool, it also allows HCPs to upload patient data to Dexcom Clarity for use in more comprehensive reports.

4. Dexcom Clarity

Using the Dexcom G6 Pro reader, you can upload patient data collected from a Dexcom G6 Pro session to Dexcom Clarity for reference during session follow-up. You can review a patient’s glucose patterns, trends, and statistics with them at this time.

5. Dexcom G6 app

If you prescribe your patient Dexcom G6 Pro for unblinded use, the patient will need to download the Dexcom G6 app (version 1.6.1 or later) for home use with their compatible smart device.*

*Compatible smart device required for patients to view real-time glucose data and receive real-time alerts when using Dexcom G6 Pro in unblinded mode and is sold separately. To view a list of compatible smart devices, visit dexcom.com/compatibility.

a simplified office workflow helps set patients up for success.

Your patients have different lifestyles, needs, and concerns. As the first and only single-use, professional CGM system available in blinded and unblinded mode, Dexcom G6 Pro allows you to align each user’s experience with his or her treatment.

Office Visit

During the initial office visit, the healthcare provider (HCP) starts the session and trains the patient. After sensor insertion and transmitter installation, the transmitter auto-starts. Then, the HCP selects blinded or unblinded mode and uses the Dexcom reader to verify session start.

Dexcom G6 Pro Session

The patient wears Dexcom G6 Pro for up to 10 days in blinded or unblinded mode. If their HCP selects unblinded mode, the patient must be able to download and use the Dexcom G6 app from a compatible smart device.*^,†

Session Follow-Up

The HCP and patient can review the data through a Dexcom Clarity report either in office or remotely^† to discuss session CGM insights. Afterward, the HCP can make appropriate treatment recommendations and submit for reimbursement for CGM setup and interpretation.

^†Patients using Dexcom G6 Pro in unblinded mode can choose to share their glucose data with their healthcare provider (HCP) via Dexcom Clarity, provided that they download the Dexcom Clarity app on a compatible smart device and successfully use the share code provided by their HCP before starting their Dexcom G6 Pro session.

the first and only single-use, professional CGM available in blinded and unblinded mode

Blinded mode

Blinded Mode

Blinded mode allows HCPs to view a patient's glucose data up to a 10-day period, without giving patients access to their data during the Dexcom G6 Pro session. Upon session completion, the patient will be able to review the data collected by Dexcom G6 Pro with their HCP, using Dexcom Clarity. From there, they can discuss the CGM data insights and any treatment recommendations.

Unblinded mode

Unblinded Mode*

Unblinded mode is indicated for diabetes management and may only be used for patients with diabetes. This mode allows patients to view and track their own real-time glucose data, giving them a greater window into their diabetes management. Patients will also be able to receive real-time hyper- and hypoglycemic alerts and make diabetes treatment decisions without fingersticks.^‡ Upon session completion, the patient will be able to review the retrospective data collected by Dexcom G6 Pro with their healthcare provider, using Dexcom Clarity. From there, they can discuss the CGM data insights and any treatment recommendations.

^‡ If your glucose alerts and readings from Dexcom G6 Pro do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

You may feel that one mode is more suitable for a patient than the other, depending on his or her individual needs, preferences, and lifestyle. Here are a few factors you can consider when choosing a mode:

Patient Considerations when Selecting Blinded or Unblinded Mode
Patient familiarity with CGM
Patient hesitancy to use a personal CGM
Patient access to a compatible smart device
Patient has or hasn't been diagnosed with diabetes
Patient experiences frequent hypoglycemic events or impaired awareness of hypoglycemia
Patient has discrepancies between their average self-monitoring of blood glucose (SMBG) readings and their A1C results

“Dexcom G6 Pro is a tool that can help us achieve better outcomes for our patients, and we get reimbursed for our time.”

- Dr. Chris Bajaj / Endocrinologist

Dr. Bajaj is a paid spokesperson of Dexcom, Inc.

Dexcom Clarity integration

Dexcom Clarity, the #1 preferred tool to support effective diabetes management for healthcare providers,² highlights patients’ glucose patterns, trends, and statistics—including time in range (TIR), time high, and time low.
Using the Dexcom G6 Pro reader, you can upload patient data to Dexcom Clarity for a comprehensive analysis.
Together, Dexcom G6 Pro and the Dexcom Clarity software give your patients a window into their glucose data, to support better diabetes management.

ready to go Pro?

See how Dexcom G6 Pro can support you, your patients, and your team.

ORDER DEXCOM G6 PRO TODAY

¹ Shah VN, et al. Diabetes Technol Ther. 2018;20(6):428-433.

² Seagrove Partners Customer Survey, August 2019.

Contact Us

If you are a healthcare provider and want to learn more about Dexcom, please fill out the form and a representative will contact you. If you are a Dexcom User or Patient, please contact Dexcom here.

Request a Visit from a Dexcom Representative

Request a G7 Sample

Request Stelo Education Materials

Please note: To ensure a successful transaction, please provide information that matches the Provider’s medical license information. A valid business address is required for a request to be fulfilled.

Do not include prefix (Mr., Mrs., Dr.)

As listed on Provider’s medical license (no MD, Jr., Sr.)

Please use the Provider's NPI

Please provide the facility address

Is your patient on a connected pump device?

Yes

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense samples of the Dexcom G6 Continuous Glucose Monitoring System and/or Dexcom‘s next generation product, Dexcom G7 (the "Samples"). I represent that I am requesting the Samples for evaluation purposes and that I will not (i) sell, resell, barter, return for credit or seek reimbursement for the use of the Samples, or (ii) for professional services for dispensing or evaluating the Samples, I also agree to inform my patients that they should not submit claims for reimbursement to any third party for any Samples.

The Samples are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither devices nor receivers are included in the Samples. Accordingly, and in light of the applicable G6 or G7 Dexcom Instructions for Use, you should dispense Samples only to a patient who (or whose authorized caregiver), in the exercise of your clinical judgment, (i) has reliable access to a compatible smart device and/or automated insulin delivery system, and (ii) is capable of safely using the Samples with their smart device, without the need for a separate dedicated receiver.

Please note that Medicare will reimburse for sensors only if the beneficiary also uses a receiver covered by Medicare. Accordingly, it is appropriate to give Samples to Medicare patients only if they have (in the case of the G6 Samples) or would be eligible to obtain (in the case of the G7 Samples), a Medicare-covered receiver.

You agree that you will not provide the Samples to any patients that are beneficiaries under the Maine or Colorado state Medicaid programs. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Samples. I agree not to reuse any Samples. I acknowledge that Dexcom provides no warranties for the Samples other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Samples, and I agree to store and use these Samples in a manner consistent with the applicable Dexcom Instructions for Use. Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

LBL-1004145 Rev001

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense these Dexcom G6 Continuous Glucose Monitoring Systems and/or Dexcom‘s next generation product, Dexcom G7 (the "Dexcom Education Devices") which are provided in the quantities listed above.

The Dexcom Education Devices are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither smart devices nor receivers are included with the Dexcom Education Devices. I understand that these Dexcom Education Devices are being requested for me and other healthcare professionals ("HCPs") for evaluation purposes to learn more about the Dexcom Education Devices and experience the benefits of the Dexcom Education Devices through a product demonstration, and that each HCP will need a compatible smart device for the product demonstration.

I acknowledge that Dexcom provides no warranties for the Dexcom Education Devices other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use, and agree not to reuse any Dexcom Education Devices. I agree to receive, store, distribute, and/or use these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use and device labeling. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Dexcom Education Devices. I understand and agree to properly dispose of the Dexcom Education Devices immediately following the completion of the product demonstration. The Dexcom Education Devices are being provided at no cost, without any expectation of remuneration, HCPs have no obligations under the federal supply schedule contract for participating in the product demonstration, and Dexcom waives any rights under this contract or applicable law to pursue a claim for the costs associated with the Dexcom Education Devices.

Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

By choosing to request info, you are granting Dexcom, Inc. permission to process your personal information to send you additional information and promotional communications related to Dexcom products. You may opt-out of these communications at any time. Dexcom respects the privacy and confidentiality of your personal information. The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.